These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8971953)

  • 21. Effect of praziquantel on hepatic fibrosis in experimental Schistosomiasis mansoni.
    el-Badrawy NM; Hassanein HI; Botros SS; Nagy FM; Abdallah NM; Herbage D
    Exp Mol Pathol; 1988 Oct; 49(2):151-60. PubMed ID: 3139442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of oxamniquine and praziquantel on intrasplenic pressure and portal vein diameter in hepatosplenic schistosomiasis.
    Massoud AM; Ghoneem M; Massoud M
    J Egypt Soc Parasitol; 1986 Dec; 16(2):427-37. PubMed ID: 3782898
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of praziquantel on the distribution of interstitial collagen types I and III and basement membrane collagen types IV and V in murine hepatic schistosomiasis.
    el-Badrawy NM; Abdel Hadi AM; Voss B; Metwally AA; Ebeid F
    Trans R Soc Trop Med Hyg; 1991; 85(6):752-5. PubMed ID: 1801346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic schistosomiasis with massive splenomegaly: a case report and literature review.
    Thijs L; Messiaen P; van der Hilst J; Madoe V; Melis C; Van Eyken P; Vanmoerkerke I; Janssens F
    Acta Gastroenterol Belg; 2018; 81(1):93-96. PubMed ID: 29562382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Praziquantel efficacy in mice infected with PZQ non-susceptible S. mansoni isolate treated with artemether: parasitological, biochemical and immunohistochemical assessment.
    Botros SS; Hammam O; Mahmoud M; Bergquist R
    APMIS; 2010 Sep; 118(9):692-702. PubMed ID: 20718722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The combined treatment of praziquantel with osteopontin immunoneutralization reduces liver damage in Schistosoma japonicum-infected mice.
    Chen BL; Zhang GY; Wang SP; Li Q; Xu MH; Shen YM; Yan L; Gu H; Li J; Huang YL; Mu YB
    Parasitology; 2012 Apr; 139(4):522-9. PubMed ID: 22309838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential immunoregulation of granulomatous inflammation, portal hypertension, and hepatic fibrosis in murine schistosomiasis mansoni.
    Olds GR; el Meneza S; Mahmoud AF; Kresina TF
    J Immunol; 1989 May; 142(10):3605-11. PubMed ID: 2497177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parasitological and immunological changes in murine hepatic schistosomiasis before and after praziquantel treatment.
    el-Shafei MM; Mattar MA; Afify HA
    J Egypt Soc Parasitol; 2002 Aug; 32(2):551-60. PubMed ID: 12214932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parasitological and histo-pathological studies on schistosomiasis mansoni infected mice and treated with praziquatel and/or oltipraz.
    Morsy GH
    J Egypt Soc Parasitol; 2009 Aug; 39(2):687-701. PubMed ID: 19795775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidental hepatic schistosomiasis in a liver transplant recipient.
    Ariza-Heredia E; Razonable RR
    Transpl Infect Dis; 2012 Feb; 14(1):75-8. PubMed ID: 21504529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variations of direct fluorescent antibody test and serum bile acids levels following praziquantel treatment in Schistosoma mansoni experimentally infected mice.
    Khalil HM; Bebars MA; Abdallah HM; el-Zayyat EA; Ismail MS
    J Egypt Soc Parasitol; 1995 Dec; 25(3):583-97. PubMed ID: 8586855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver disease in Egypt: hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors.
    Strickland GT
    Hepatology; 2006 May; 43(5):915-22. PubMed ID: 16628669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pharmacological approach to reverse portal hypertention and hepatic schistosomal fibrosis in Egypt, control experimental study.
    Helmy AH; Abdel-Hady AA; el-Shanawany F; Hammam O; Abdel-Hady A
    J Egypt Soc Parasitol; 2005 Dec; 35(3):731-50. PubMed ID: 16333884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of hepatosplenic Schistosomiasis mansoni with praziquantel. Preliminary report on tolerance and efficacy.
    Coutinho A; Domingues AL; Neves J; Almeida ST
    Arzneimittelforschung; 1983; 33(5):787-91. PubMed ID: 6683560
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of acute experimental schistosomiasis.
    Andrade ZA; de Azevedo TM
    Mem Inst Oswaldo Cruz; 1989; 84(4):477-84. PubMed ID: 2487444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Active and latent collagenase activity during reversal of hepatic fibrosis in murine schistosomiasis.
    Emonard H; Grimaud JA
    Hepatology; 1989 Jul; 10(1):77-83. PubMed ID: 2544498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacodynamics of pentoxifylline and/or praziquantel in murine schistosomiasis mansoni.
    El-Lakkany N; Nosseir M
    APMIS; 2007 Mar; 115(3):184-94. PubMed ID: 17367463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of colchicine on hepatic glycosaminoglycan metabolism in mice infected with Schistosoma japonicum.
    Si Q; Zhang Y; Wang QH; Zhuang QQ; Mei MZ
    Zhongguo Yao Li Xue Bao; 1995 Jan; 16(1):39-42. PubMed ID: 7771194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver morbidity due to Schistosoma mekongi in Cambodia after seven rounds of mass drug administration.
    Keang H; Odermatt P; Odermatt-Biays S; Cheam S; Degrémont A; Hatz C
    Trans R Soc Trop Med Hyg; 2007 Aug; 101(8):759-65. PubMed ID: 17568642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of anti-schistosomal treatment on schistosomal hepatic pathology: an experimental study in Syrian golden hamsters.
    Moustafa FE; Hamouda MM; el-Shazly AM; Sheha G; Hamid S; el-Naggar HM; Habib FS; Morsy TA
    J Egypt Soc Parasitol; 1996 Aug; 26(2):517-24. PubMed ID: 8754659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.